Safety Study of a Chemokine Receptor (CXCR4) Antagonist in Multiple Myeloma Patients

NCT01010880 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
16
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Biokine Therapeutics Ltd